Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota

• Main Authors: Liang Tian (Author), Chongfei Huang (Author), Wenkang Fu (Author), Long Gao (Author), Ningning Mi (Author), Mingzhen Bai (Author), Haidong Ma (Author), Chao Zhang (Author), Yawen Lu (Author), Jinyu Zhao (Author), Xianzhuo Zhang (Author), Ningzu Jiang (Author), Yanyan Lin (Author), Ping Yue (Author), Jinqiu Yuan (Author), Wenbo Meng (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Proton pump inhibitors (PPIs) are the most used acid-inhibitory drugs, with a wide range of applications in the treatment of various digestive diseases. However, recently, there has been a growing number of digestive complications linked to PPIs, and several studies have indicated that the intestina...